BioSpace News Archive

Latest advancements in Artificial Intelligence research can potentially help healthcare providers impact patient care and improve workflows in the ER, OR and General X-ray

Continues expansion of enhanced imaging technology solutions designed for hospitals and outpatient applications at RSNA

TraceLink Inc. announced financial and company results for the third quarter of 2019.

American Association of Endodontists members from Boston, Harvard and Tufts Dental Schools form trifecta of free care on Teeth Worth Saving Day

Series of educational workshops designed to educate radiologists, administrators, technologists on the potential benefits of the latest breast cancer screening technology

Forward-thinking design eliminates traditional glass substrate from the capture layer, the most fragile layer inside.

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.

Blue Cross Blue Shield of Massachusetts announced the five nonprofit recipients of its new Healthy Living Accelerator Grants. The Healthy Living Accelerator Grants fund unique and innovative programs and initiatives that influence behavior change and advance the health of Massachusetts residents by addressing the inter-connectedness of healthy eating, active lifestyles, and positive environments.

Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.

Elios Therapeutics, a biopharmaceutical company developing innovative personalized therapeutic cancer vaccines, today announced that the Company presented the primary analysis of the prospective, randomized, double-blind, placebo-controlled Phase IIb clinical trial evaluating its tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine, in patients with Stage III and IV resected melanoma.